Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov 27;13(1):44-50.
doi: 10.1038/ni.2172.

Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner

Affiliations

Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner

Irah L King et al. Nat Immunol. .

Abstract

Mouse invariant natural killer T cells (iNKT cells) provide cognate and noncognate help for lipid and protein-specific B cells, respectively. However, the long-term outcome for B cells after cognate help is provided by iNKT cells is unknown at present. Here we found that cognate iNKT cell help resulted in a B cell differentiation program characterized by extrafollicular plasmablasts, germinal-center formation, affinity maturation and a robust primary immunoglobulin G (IgG) antibody response that was uniquely dependent on iNKT cell-derived interleukin 21 (IL-21). However, cognate help from iNKT cells did not generate an enhanced humoral memory response. Thus, cognate iNKT cell help for lipid-specific B cells induces a unique signature that is a hybrid of classic T cell-dependent and T cell-independent type 2 B cell responses.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Cognate (lipid) and non-cognate (lipid plus protein) antigen stimulation of B cells induces splenic extrafollicular foci.
(a-d) 7 μm sections of OCT-embedded spleens from B1-8 Tg mice were labeled with anti-CD19 (green), anti-CD138 (red), NP-APC (blue) to identify CD138+ NP-specific plasmablasts. High resolution, knitted images of these spleen sections were captured by confocal microscope 5 days after immunization with 5 μg NP−α−GalCer (a) 100 μg NP-KLH + 5 μg α−GalCer (b), 100 μg NP-KLH + alum (c), or PBS-DMSO (d). Data are representative from 3-4mice per group in 2 independent experiments; scale bar = 100μm. (e, f) Flow cytometry analysis of splenic NP-specific IgD, B220loCD138+ plasmablast B cells from identically immunized WT C57BL/6 mice in representative plots (e) and as a summary (f). (g) ELISPOT enumeration of NP-specific IgG secreting splenic B cells. (h) the number of TCRβ+CD1dtet+ iNKT cells from the same mice as determined by flow cytometry. Each symbol represents an individual mouse; representative (g) or pool (f, h) of 5 mice per group from 2 independent experiments; bar = mean. Unpaired two-tailed t-tests were performed for large data sets [f, i], Mann-Whitney tests were performed for small data set [h] *P≤0.05,**P≤0.001
Figure 2
Figure 2. Cognate (lipid) and non-cognate (lipid plus protein) antigen stimulation of B cells leads to development of splenic germinal centers.
(a-d) 7 μm sections of OCT-embedded spleens from B1-8 transgenic mice were labeled with GL-7 (green), anti-CD3 (blue), and anti-CD19 (red). High resolution, knitted images of these spleen sections were captured by confocal microscope and represent duplicate sections of 4 mice/group collected 12 days after immunization with 5 μg NP−α−GalCer (a), 100 μg NP-KLH + 5 μg α−GalCer (b), 100 μg NP-KLH (c), and PBS-DMSO (d). (4mice/group, representative of 2-3 independent experiments) scale bar=500μm. Images enabled determination of total number of GL7+ GCs per spleen section (e). (f, g) Flow cytometry analysis of day 12 spleen cells from identically immunized C57BL/6 WT mice was used to quantitate CD19+CD95+GL7+ gerinal cell numbers per spleen (f), and IgD CD38+NP-specific B cells (g). (h)ELISPOT analysis of NP-specific IgG secreting splenic B cells from WT C57BL/6 mice. (i) TCRβ+CD1dtet+ iNKT cells were also enumerated by flow cytometry. Each symbol represents an individual mouse; bar = mean. 4-5 mice per group from representative (f, h, i) or pool (e,g) of 2-3 independent experiments. Mann-Whitney test * P≤0.05,**P≤0.001.
Figure 3
Figure 3. Cognate and non-cognate iNKT cell help both induce antigen-specific antibody affinity maturation
Sera was collected 7 days after primary challenge and 7 days after secondary boost (day 61) from C57BL/6 WT mice immunized with 0.5 μg NP−α−GalCer, 100 μg NP-KLH/ 0.5 μg α−GalCer, 100 μg NP-KLH + alum, or 30 μg NP68-Ficoll and tested by ELISA on plates coated with NIP5BSA vs NIP15BSA. Affinity maturation is expressed as ratio of NP4/NP25 binding as assessed by O.D. Each symbol represents an individual mouse; bar = mean. 8-10 mice per group, representative of 3 independent experiments. * P≤0.0001.
Figure 4
Figure 4. IL-21 receptor signaling is required for cognate iNKT cell-mediated anti-NP antibody responses.
(a, b) C57BL/6 WT and Il21r deficient mice were immunized with 0.5 μg NP−α−GalCer, 100 μg NP-KLH + 0.5 μg α−GalCer, 100 μg NP-KLH + alum, or 30 μg NP(68)-Ficoll. Mice were bled on days 0, 7, 14 and 21 and assessed for IgG (a) and IgM (b) anti-NIP titers. (Summary of 2-5 independent experiments with 3-5 mice per group in each experiment; mean and s.e.m.) * p≤0.05 **P≤0.001 for comparisons between WT and IL-21R-KO pairs. (c) TCRβ+CD19CD1d tetramer–positive iNKT cells were sorted by flow cytometry from Vα14 transgenic mice at 1 day, 1 week (days 5-7), and 2 weeks (days 11-13), following IP immunization with 0.5 μg NP−α−GalCer per mouse or DMSO. Real-time RT-PCR was performed to assess IL-21 mRNA expression in iNKT cells. (data shown are pooled from 2-3 experiments and include 5-11 mice per group; mean and s.e.m.) **P≤0.001
Figure 5
Figure 5. iNKT-produced IL-21 is required for cognate lipid antigen help.
(a,b,c) Mixed bone marrow chimeras with an iNKT cell compartment capable (WT) or incapable of producing IL-21 (Il21-KO) were immunized with 0.5 μg NP−α−GalCer, 100 μg NP-KLH + 0.5 μg α−GalCer, or 100 μg NP-KLH + alum. Mice were bled on day 8 (a), day 14 (b), and day 21 (c) and assessed for anti-NIP IgG titers. (Summary of 2 independent experiments, with 3-5 mice per group in each experiment; mean and s.e.m.) * P≤0.05 for comparisons between WT and Il21 deficient pairs.
Figure 6
Figure 6. Only non-cognate iNKT cell help induces antibody memory response after day 177 rechallenge.
(a,b) C57BL/6 WT mice were immunized IP on day 0 with PBS + alum, PBS, or 2.2 μg NP-KLH + alum (a) or 0.5 μg NP−α−GalCer (b). Mice were bled periodically up to day 166. Mice then received a secondary boost IV on day 177 with 2.2 μg NP-KLH + PBS (or IP with alum as noted), 0.5 μg NP−α−GalCer antigen, or PBS and were bled again on days 3, 7, and 14 post-boost. Legend indicates primary challenge; secondary boost. Concentration of NP-specific IgG was determined by anti-NIP5 ELISA. (One experiment with 10 mice per group; mean ± s.e.m.) * P≤0.05, **P≤0.001 as compared to PBS; NP-KLH + alum group (□). For full time-course see Supplementary Fig. 3.
Figure 7
Figure 7. Only non-cognate iNKT cell help induces antibody memory response after day 46 rechallenge.
(a,b) C57BL/6 WT mice were immunized IP on day 0 with 2.2 μg NP-KLH in alum, 2.2 μg NP-KLH plus 0.5 μg α−GalCer (a), 0.5 μg NP−α−GalCer, or 30 μg NP(68)-Ficoll (b) and were bled periodically up to day 45. Mice then received a secondary boost IP on day 46 with the same doses of NP-KLH (±alum), NP-KLH + α−GalCer (a), NP−α−GalCer, NP68-Ficoll or PBS (b) and were bled again on days 3, 7, 14, and 29 post-boost. Key indicates primary challenge; secondary boost. Concentration of NP-specific IgG was determined by anti-NIP5 ELISA. (One experiment with 10mice per group; mean ± s.e.m.) * P≤0.05, **P≤0.001 as compared to relevant primary immunization group (□ or ○). For full time-course see Supplementary Fig. 4.

Comment in

References

    1. MacLennan IC, et al. Extrafollicular antibody responses. Immunol Rev. 2003;194:8–18. - PubMed
    1. Jacob J, Kelsoe G, Rajewsky K, Weiss U. Intraclonal generation of antibody mutants in germinal centres. Nature. 1991;354:389–392. - PubMed
    1. Leadbetter EA, et al. NK T cells provide lipid antigen-specific cognate help for B cells. Proc Natl Acad Sci U S A. 2008;105:8339–8344. - PMC - PubMed
    1. Barral P, et al. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc Natl Acad Sci U S A. 2008;105:8345–8350. - PMC - PubMed
    1. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what’s in a name? Nat Rev Immunol. 2004;4:231–237. - PubMed

Publication types

LinkOut - more resources